about
The emerging roles of inositol pyrophosphates in eukaryotic cell physiologySeed Biofortification and Phytic Acid Reduction: A Conflict of Interest for the Plant?The Obesity-Linked Gene Nudt3 Drosophila Homolog Aps Is Associated With Insulin SignalingIdentification of a functional nuclear translocation sequence in hPPIP5K2.Inositol Pyrophosphate Profiling of Two HCT116 Cell Lines Uncovers Variation in InsP8 Levels.Synthetic tools for studying the chemical biology of InsP8.Identification of a major IP5 kinase in Cryptococcus neoformans confirms that PP-IP5/IP7, not IP6, is essential for virulenceInositol hexakisphosphate (IP6) generated by IP5K mediates cullin-COP9 signalosome interactions and CRL function.Inositol Hexakisphosphate Kinase 3 Regulates Metabolism and Lifespan in Mice.Inositol polyphosphates intersect with signaling and metabolic networks via two distinct mechanisms.The Significance of the Bifunctional Kinase/Phosphatase Activities of Diphosphoinositol Pentakisphosphate Kinases (PPIP5Ks) for Coupling Inositol Pyrophosphate Cell Signaling to Cellular Phosphate Homeostasis.Towards pharmacological intervention in inositol pyrophosphate signalling.Importance of Radioactive Labelling to Elucidate Inositol Polyphosphate SignallingChemical Approaches to Studying Labile Amino Acid Phosphorylation.Intimate connections: Inositol pyrophosphates at the interface of metabolic regulation and cell signaling.Has Inositol Played Any Role in the Origin of Life?Cellular Cations Control Conformational Switching of Inositol Pyrophosphate Analogues.Conjecture Regarding Posttranslational Modifications to the Arabidopsis Type I Proton-Pumping Pyrophosphatase (AVP1).IP3-4 kinase Arg1 regulates cell wall homeostasis and surface architecture to promote clearance of Cryptococcus neoformans infection in a mouse model.The inositol pyrophosphate pathway in health and diseases.The inositol pyrophosphate synthesis pathway in Trypanosoma brucei is linked to polyphosphate synthesis in acidocalcisomes.Drug-resistance in doxorubicin-resistant FL5.12 hematopoietic cells: elevated MDR1, drug efflux and side-population positive and decreased BCL2-family member expression.
P2860
Q26786441-56B94C77-D8FB-4642-A630-7E6DAD0FBB86Q27005574-DFE44961-97CE-4A4A-9268-700AFE57CA80Q33631545-AED214E0-B51A-436A-90B3-DBDFC1FFBAF2Q34481151-C3A47373-0E22-4162-BF5C-498CE0D54D6BQ36176216-3EF0452A-E02C-47AB-BB62-BEB12EA1A035Q36276824-1AAD812D-6B46-4E30-8AF2-C238162AEED2Q36754718-0D6C604F-3F61-422B-9B58-110A7BA98422Q36770693-4F9CFCB3-19F8-4F43-A4C9-AC4F44D0AA24Q37219919-F72D4CB7-934C-488E-8F17-8D959BB71D5BQ37398176-ED67813D-29C4-46A9-B3C3-5CA8001EA45BQ38719227-A997C1D4-FB14-45AC-85CC-8371FCAD2435Q38728101-4B4CB901-5F47-4B4E-B857-68ABC3E33896Q39094564-E2ADF5E8-3D1A-4E7C-8220-8A46B3FC4AE4Q39123781-8DB42627-07C0-4C72-BDD1-CDBCC8ED6475Q39329205-AA47BAF6-F32A-4A93-AF76-820506D8D38FQ40994832-2BDB5097-FAB8-4CCF-8CD5-92CBA7D88D0BQ41549123-F1FE16C4-A2CD-492E-9C70-CDC403374771Q41684642-59B13CB7-8D09-4652-9DA3-B643DD2F713DQ41991339-C60FDB7F-B5C9-4881-9194-29762EBA982CQ47250401-BC380A4F-C2F0-4D18-B4B2-7A88E4B0D8B9Q47974011-E503A19A-825A-4CB2-BAB4-374C2DF4522BQ49882954-CD88978F-C6D5-4CAF-A7C2-D6C0529FADB1
P2860
description
2015 nî lūn-bûn
@nan
2015 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Inositol pyrophosphates: why so many phosphates?
@ast
Inositol pyrophosphates: why so many phosphates?
@en
Inositol pyrophosphates: why so many phosphates?
@nl
type
label
Inositol pyrophosphates: why so many phosphates?
@ast
Inositol pyrophosphates: why so many phosphates?
@en
Inositol pyrophosphates: why so many phosphates?
@nl
prefLabel
Inositol pyrophosphates: why so many phosphates?
@ast
Inositol pyrophosphates: why so many phosphates?
@en
Inositol pyrophosphates: why so many phosphates?
@nl
P2860
P3181
P1476
Inositol pyrophosphates: why so many phosphates?
@en
P2093
Stephen B Shears
P2860
P304
P3181
P356
10.1016/J.JBIOR.2014.09.015
P407
P577
2015-01-01T00:00:00Z